Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
FOXO4-DRI 10mg vial FOXO4-DRI (FOXO4-D-Retro-Inverso peptide) is a synthetic peptide designed as a selective senolytic agent, initially developed by researchers at Erasmus Price: 50.00 Collection: Peptides Batch test results and COAs Research use only
When your team reconstitutes this vial with 3mL of Sterile Bacteriostatic Water , the resulting concentration yields a highly predictable measurement curve
Largest human dataset / Khavinson longitudinal cohort, approximately 266 participants over 15 years Primary proposed mechanism / telomerase reverse transcriptase (hTERT) activation in somatic cells Published serious adverse events / none reported in available literature, though reporting quality is low Typical research protocol / 5 to 10 mg subcutaneous daily for 10 to 20 days, cycled every 4 to 6 months Controlled Phase II or III trials / zero completed in Western regulatory frameworks Age-specific safety data for 30 to 49 / not isolated in any published study Drug interaction studies / none published What Is Epitalon and Why Does It Matter for This Age Group
DSIP Dosage Chart by Administration Route Heres a practical framework based on the available evidence: The subcutaneous protocol used today is based on decades of field experimentation by clinicians, peptide researchers, and experienced biohackers
El Pptido Inductor del Sueo Delta, o Delta Sleep Inducing Peptide, es un nonapptido que afecta la autorregulacin neuronal y se encuentra tpicamente en el cerebro, cruzando rpidamente la barrera hematoenceflica
Important note: it remains investigational and lacks FDA approval for human use
US$ 20.96
US$ 22.87
US$ 20.39
US$ 21.57
US$ 28.96
US$ 29.90
US$ 22.42
